DGAP-PVR: RHÖN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

| Source: EQS Group AG EQS Group AG 

RHÖN-KLINIKUM AG 

22.12.2014 15:34

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


Notification pursuant to sec. 26 para. 1 of the German Securities Trading
Act (Wertpapierhandelsgesetz - WpHG)

Dr. Ulrich Wandschneider (CEO) and Dipl.-Kfm. Stephan Leonhard (Deputy CEO,
CFO) notified us for and on behalf of Dr. Bernard gr. Broermann, business
domicile at Debusweg 3, 61462 Königstein-Falkenstein and Asklepios Kliniken
GmbH, Debusweg 3, 61462 Königstein-Falkenstein, Deutschland (the
aforementioned persons are collectively named the 'Notifying Persons'
hereafter) of the following on 18 December 2014:

The Notifying Persons are referring to their notifications according to
sec. 21 and 22 of the German Securities Trading Act
(Wertpapierhandelsgesetz - WpHG) concerning RHÖN-KLINIKUM
Aktiengesellschaft ('Corporation') of 21 November 2014.

With respect to the objectives pursued with the acquisition of the voting
rights, the Notifying Persons have informed us according to Section 27a
para 1 sentence 1 and 3 of the German Securities Trading Act, that:

 1. The Notifying Persons consider the holding in the corporation as a
    long-term strategic investment.

 2.  The Notifying Persons are eventually willing to obtain further voting
    rights by acquisition or any other way within the next 12 month -
    depending on the share price and the general performance of the
    corporation.

 3. The Notifying Persons intend to obtain an appropriate representation on
    the supervisory board and intend to execute their voting rights
    accordingly.

 4. The Notifying Persons do not intend to essentially change the capital
    structure of the corporation, especially with regards to the ratio of
    internal/outside financing and the dividend policy.

Moreover the Notifying Persons informed us according to section 27a para 1
sentence 1 and 4 of the German Securities Trading Act with respect to the
origin of the used funds for the acquisition of the voting rights, that:

The Notifying Persons financed the acquisition by own funds. 
 
Bad Neustadt a. d. Saale, 22 December 2014

The Board of Management

Dr. Kai G. Klinger
SVP - Investor Relations, Corporate Finance and M&A
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65 - 1318
Fax: +49 9771 99 - 1736



22.12.2014 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      RHÖN-KLINIKUM AG
              Schlossplatz 1
              97616 Bad Neustadt a.d.Saale
              Germany
Internet:     www.rhoen-klinikum-ag.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------